Total Raised

$306.3M

Deal Terms

3

Insilico Medicine Funding, Insilico Medicine Valuation & Insilico Medicine Revenue

8 Fundings

Insilico Medicine's latest funding round was a Series C for $255M on June 22, 2021.

Insilico Medicine's latest post-money valuation is from June 2021.

Sign up for a free trial to see Insilico Medicine's valuations in June 2021 and more.

Insilico Medicine's 2016 revenue was <$1M. Insilico Medicine's most recent revenue is from 2016.

Sign up for a free trial to see revenue data from 2016 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/22/2021

Series C

$255M

$99M

0

FY undefined

38

9/10/2019

Series B

$99M

0

FY undefined

10

6/11/2018

Series A - III

$99M

0

FY undefined

10

8/16/2017

Partnership

<$1M

FY 2016

10

7/18/2017

Series A - II

$99M

$0.00B

((9.99x))

FY 1234

10

Date

6/22/2021

9/10/2019

6/11/2018

8/16/2017

7/18/2017

Round

Series C

Series B

Series A - III

Partnership

Series A - II

Amount

$255M

$99M

$99M

$99M

Investors

Valuation

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

<$1M

FY 2016

$0.00B

((9.99x))

FY 1234

Sources

38

10

10

10

10

Insilico Medicine Deal Terms

3 Deal Terms

Insilico Medicine's deal structure is available for 3 funding rounds, including their Series C from June 22, 2021.

Round

Series C

Series A - III

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series C

$99M

$99M

$99M

$99M

$99M

$99M

Series A - III

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

You May Also Like

Atomwise Logo
Atomwise

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID.

insitro Logo
insitro

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

Cyclica Logo
Cyclica

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

GNS Healthcare Logo
GNS Healthcare

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Healx Logo
Healx

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform leverages public and proprietary biomedical data and features a knowledge graph for rare diseases.

Aria Pharmaceuticals Logo
Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that discovers and develops novel small molecule therapies for complex and hard-to-treat diseases

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.